Literature DB >> 27249185

Sequential transurethral enucleation of the prostate and laparoscopic bladder diverticulectomy.

Yang Yu1, Sheng Guan1, Chen Shen1, Bo Yang1.   

Abstract

Transurethral endoscopic technique and standard laparoscopic technique are surgical options for the management of benign prostatic hyperplasia (BPH) associated with urinary bladder diverticuli (UBD). In this article, we report laparoscopic diverticulectomy (LD) and transurethral plasmakinetic enucleation of the prostate (TUEP) in the same patient sequentially. To the best of our knowledge, this is the first case report of LD combined with TUEP. An 82-year-old patient with benign prostatic hyperplasia and two secondary large bladder diverticuli underwent sequential TUEP and LD. After completion of the TUEP procedure, the detached adenoma was pushed into the bladder as a whole. Then laparoscopic transperitoneal extravesical diverticulectomy assisted by cystoscopic transillumination was performed immediately, and the enucleated prostate was removed via the neck of the diverticulum. The enucleation time and diverticulectomy time was 18 minutes and 108 minutes, respectively. The catheter was removed on the tenth postoperative day. Transurethral endoscopic surgery combined with LD is a good choice in treating BPH and UBD in one session. But the combined procedure is time-consuming, especially for fragmentation of the prostate. TUEP can greatly reduce the operative time of the combined procedure.

Entities:  

Keywords:  BPH; Endoscopy; TUEP; bladder diverticula; laparoscopic diverticulectomy; minimally invasive procedures; technology

Mesh:

Year:  2016        PMID: 27249185     DOI: 10.1080/13645706.2016.1181091

Source DB:  PubMed          Journal:  Minim Invasive Ther Allied Technol        ISSN: 1364-5706            Impact factor:   2.442


  1 in total

1.  Firefly® System and Organ Transillumination in Robotic Gynecologic Surgery.

Authors:  Maurizio Rosati; Silvia Bramante; Alessandro Vigone; Martina Gerbino; Fiorella Conti; Serena Mauri; Daniela Surico
Journal:  JSLS       Date:  2021 Jul-Sep       Impact factor: 2.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.